Harnessing Integrative Structural Biology Techniques Including NMR, X-Ray Crystallography, Cryo-EM, & Cryo-ET to Determine 3D Structures of Pharmacologically Relevant Targets & Propel Drug Design

Have you heard the boom created by Cryo-EM? Drug development has been shaken up with the application of Cryo-EM, accelerating and increasing the rate of success of protein targeting by identifying new ways to treat diseases with greater sensitivity and efficiency in the study of 3D structures. Structural biologists, medicinal chemists, and computational chemists need to assess the experimental methods by sharing case study presentations to streamline, rationalize, and optimize drug design.

The inaugural Structure-Based Drug Design Summit  is your opportunity to assess the resolution and speed of the techniques in the toolbox to answer structural biology questions for drug design, assess the gaps, and implement newer techniques for increased specificity and precision

Sharing cutting-edge structural biology methods and applications, including harnessing Cryo-EM and Cryo-ET to visualize protein interactions, structure-based methods as a package of techniques to study integrated biological systems, and incorporating computational methods as a predictive tool for structures; this is a unique opportunity to come together and rationalize drug design by understanding the 3D structure of proteins. Join 50+ industry scientists to delve into 3D protein structure determination using NMR, X-Ray Crystallography, Cryo-EM, and Cryo-ET, to improve resolution and efficiency and rationalize drug development.

Revolutionize the way drugs are discovered and developed to lead to newer and more effective therapeutics for a wide range of diseases, build the complete 3D picture, and go after undruggable targets.